Similar articles for PMID: 17094387

Year	Number of Results
1962	1
1986	2
1989	1
1991	2
1992	1
1994	1
1995	1
1997	2
1998	3
1999	2
2001	2
2002	4
2003	6
2004	9
2005	3
2006	11
2007	11
2008	14
2009	15
2010	2
2011	2
2012	2
2013	1
2016	5
2017	1
2020	1
2021	1
2022	1
2023	1
2024	3

1

Randomized controlled clinical trial of a combination of somatostatin analog and dexamethasone plus zoledronate vs. zoledronate in patients with androgen ablation-refractory prostate cancer.

Mitsiades CS, Bogdanos J, Karamanolakis D, Milathianakis C, Dimopoulos T, Koutsilieris M. Mitsiades CS, et al. Anticancer Res. 2006 Sep-Oct;26(5B):3693-700. Anticancer Res. 2006. PMID: 17094387 Free article. Clinical Trial.

2

Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.

Koutsilieris M, Mitsiades CS, Bogdanos J, Dimopoulos T, Karamanolakis D, Milathianakis C, Tsintavis A. Koutsilieris M, et al. Clin Cancer Res. 2004 Jul 1;10(13):4398-405. doi: 10.1158/1078-0432.CCR-04-0077. Clin Cancer Res. 2004. PMID: 15240528

3

A combination therapy of dexamethasone and somatostatin analog reintroduces objective clinical responses to LHRH analog in androgen ablation-refractory prostate cancer patients.

Koutsilieris M, Mitsiades C, Dimopoulos T, Ioannidis A, Ntounis A, Lambou T. Koutsilieris M, et al. J Clin Endocrinol Metab. 2001 Dec;86(12):5729-36. doi: 10.1210/jcem.86.12.8119. J Clin Endocrinol Metab. 2001. PMID: 11739429

4

Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancer.

Borden LS Jr, Clark PE, Lovato J, Hall MC, Stindt D, Harmon M, M Mohler R, Torti FM. Borden LS Jr, et al. Cancer. 2006 Sep 1;107(5):1093-100. doi: 10.1002/cncr.22078. Cancer. 2006. PMID: 16888761 Free article. Clinical Trial.

5

Response of patients with advanced prostatic cancer to administration of somatostatin analog RC-160 (vapreotide) at the time of relapse.

González-Barcena D, Schally AV, Vadillo-Buenfil M, Cortez-Morales A, Hernández L V, Cardenas-Cornejo I, Comaru-Schally AM. González-Barcena D, et al. Prostate. 2003 Aug 1;56(3):183-91. doi: 10.1002/pros.10232. Prostate. 2003. PMID: 12772187

6

Randomized comparison of total androgen blockade alone versus combined with weekly epirubicin in advanced prostate cancer.

Pummer K, Lehnert M, Stettner H, Hubmer G. Pummer K, et al. Eur Urol. 1997;32 Suppl 3:81-5. Eur Urol. 1997. PMID: 9267791 Clinical Trial.

7

Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer.

Trump DL, Potter DM, Muindi J, Brufsky A, Johnson CS. Trump DL, et al. Cancer. 2006 May 15;106(10):2136-42. doi: 10.1002/cncr.21890. Cancer. 2006. PMID: 16598750 Free article. Clinical Trial.

8

High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.

Morris MJ, Smaletz O, Solit D, Kelly WK, Slovin S, Flombaum C, Curley T, Delacruz A, Schwartz L, Fleisher M, Zhu A, Diani M, Fallon M, Scher HI. Morris MJ, et al. Cancer. 2004 May 1;100(9):1868-75. doi: 10.1002/cncr.20185. Cancer. 2004. PMID: 15112267 Free article.

9

A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer.

Flaig TW, Barqawi A, Miller G, Kane M, Zeng C, Crawford ED, Glodé LM. Flaig TW, et al. Cancer. 2006 Jul 15;107(2):266-74. doi: 10.1002/cncr.21982. Cancer. 2006. PMID: 16779800 Free article. Clinical Trial.

10

Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.

Rosenthal SA, Bae K, Pienta KJ, Sobczak ML, Asbell SO, Rajan R, Kerlin KJ, Michalski JM, Sandler HM; Radiation Therapy Oncology Group Trial 9902. Rosenthal SA, et al. Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):672-8. doi: 10.1016/j.ijrobp.2008.05.020. Epub 2008 Nov 5. Int J Radiat Oncol Biol Phys. 2009. PMID: 18990504 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 17094387

104 results

Results by year